Pharmacovigilance – News and Features

UCSD study evaluated microdroplet PCR’s advantages in performing sequence enrichment for targeted sequencing over traditional PCR approach.

Biota Holdings Limited and Daiichi Sankyo Co., Ltd. today announced the commencement of the Phase III trial for the anti-influenza drug, CS-8958, in Japan.

The Partnerships with CROs event is now known as Partnerships in Clinical Trials.

Primary efficacy endpoint met in two pivotal Phase 3 trials, as specified by Special Protocol Assessment agreement with FDA.

NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months.

Contract will support expanded rollout of Phase Forward’s WebSDM product with clinical trials signal detection at FDA CDER.

Study to determine whether lower blood pressure goal cuts the risk of heart and kidney diseases, stroke, and cognitive decline.

PMX-60056 Heptagonist meets safety and efficacy endpoints in reversing effects of Heparin.

Roche and Fluofarma will work together to develop a hepatotoxicity prediction tool based on HCS that may lead to future increased synergies.

Study to focus on immunotherapy for treatment of idiopathic CD4 lymphocytopenia, a rare condition for which no treatment currently exists.